Mineralys Therapeutics

MLYS · NASDAQ

$21.58+$0.66 (+3.15%)TodayMarket closed ·
Prev close $20.92

Who owns MLYS

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 51.8% of MLYS’s shares.

  • Catalys Pacific, LLC9.0%
  • RA Capital Management, LP8.7%
  • Samsara BioCapital, LLC6.7%
  • BlackRock Institutional Trust Company, N.A.5.6%
  • Next 6 largest institutions21.9%
  • All other shareholders48.2%
Top institutional holders of MLYS
HolderShares% of shares
Catalys Pacific, LLC7.90M8.97%
RA Capital Management, LP7.69M8.73%
Samsara BioCapital, LLC5.87M6.66%
BlackRock Institutional Trust Company, N.A.4.90M5.56%
State Street Investment Management (US)4.14M4.70%
Deerfield Management Company, L.P.3.96M4.49%
Fidelity Management & Research Company LLC3.78M4.29%
Vanguard Capital Management, LLC2.76M3.13%
Laurion Capital Management LP2.51M2.84%
T. Rowe Price Associates, Inc.2.18M2.47%

Largest mutual fund holders

Top mutual fund holders of MLYS
HolderShares% of shares
State Street SPDR S&P Biotech ETF2.97M3.37%
Vanguard Total Stock Market Index Fund1.97M2.23%
American Funds SMALLCAP World Fund1.94M2.21%
iShares Russell 2000 ETF1.49M1.69%
Polar Capital Biotechnology Fund1.35M1.53%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $7.46M (18 trades) of MLYS on the open market, with no buys.

Latest MLYS insider transactions
InsiderTypeSharesValue
Congleton JonSale75.00K$1.91M
Slingsby Brian TaylorSale104.32K$3.01M
Warren EricOption exercise7.44K—
Warren EricSale7.44K$209.14K
Warren EricOption exercise7.44K$98.48K
Karydas DaphneOption exercise3.00K—
Karydas DaphneSale3.00K$85.74K
Karydas DaphneOption exercise3.00K$36.06K
Warren EricOption exercise7.44K—
Warren EricSale7.44K$193.19K

Short interest

Settled Sep 30, 2026

Shares short
7.81M
Days to cover
5.16
% of shares outstanding
8.86%
Average daily volume
1.51M
Change since last report
−15.0%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.